Porous Elastomer Implant Surface Reduces Fibrous Capsule Formation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Implantable medical devices often induce a foreign body response leading to fibrous capsule formation and capsular contracture, which can cause aesthetic and painful issues, and current textured surface approaches do not fully prevent these complications.
Innovation Solution
A biocompatible implantable device featuring a porous material with an elastomer matrix and interconnected pores, providing high porosity and elastic elongation to promote tissue growth and reduce fibrous capsule formation, while maintaining mechanical strength.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If a smooth surface is used on implantable medical devices, then manufacturing is simple, but fibrous capsule formation and capsular contracture occur
Solution Approach 1:
The patent applies porous materials with controlled pore sizes (5-50 micrometers) and high porosity (80-90%) to the implantable device surface. This porous structure promotes cellular ingrowth and tissue integration, effectively preventing fibrous capsule formation and capsular contracture while maintaining manufacturing feasibility through techniques like phase separation and foam replication
Solution Approach 2:
The patent uses composite materials combining elastomer matrices with porous structures and various additives (plasticizers, crosslinking agents, bioactive molecules). These composite materials provide both the mechanical properties needed for implantability and the biological functionality to prevent capsular contracture, resolving the contradiction between simple manufacturing and harmful fibrous capsule formation
2Object-affected harmful factors
If the surface is textured with hills and valleys, then capsular formation is reduced, but capsular contracture can still occur and manufacturing complexity increases
Solution Approach 1:
The patent transitions from simple hill-and-valley texturing to a sophisticated porous structure with interconnected pores of controlled size (5-50 micrometers). This porous architecture more effectively prevents both capsular formation and contracture by promoting cellular ingrowth throughout the surface, while the manufacturing processes (phase separation, foam replication) keep complexity manageable
Solution Approach 2:
The patent applies different pore sizes, distributions, and densities in different regions of the implant surface to optimize local biological responses. This local quality approach enhances prevention of capsular contracture in critical areas while maintaining overall structural integrity and manageable manufacturing complexity
3Object-affected harmful factors
If porosity is increased to promote cellular ingrowth, then fibrous capsule formation is reduced, but mechanical strength may be compromised
Solution Approach 1:
The patent employs composite elastomer materials with crosslinked networks and reinforcement phases that maintain high mechanical strength even at 80-90% porosity. The composite structure includes elastomer matrices with controlled crosslinking densities and potential reinforcement from nanomaterials or fiber networks, allowing high porosity for cellular ingrowth while preserving the mechanical strength needed for implantable devices
Solution Approach 2:
The patent optimizes multiple parameters simultaneously: pore size (5-50 micrometers), porosity (80-90%), elastomer composition, crosslinking density, and pore wall thickness. By carefully controlling these parameters, the material achieves both high cellular ingrowth capability and sufficient mechanical strength for implantable applications, resolving the contradiction between fibrous capsule prevention and mechanical strength
4Adaptability or versatility
If elastic elongation is increased to at least 80%, then tissue integration is improved, but material structural stability may be reduced
Solution Approach 1:
The patent uses composite elastomer structures with crosslinked networks that provide both high elastic elongation (≥80%) and structural stability. The composite architecture includes flexible polymer chains for elasticity combined with crosslinking points and potential rigid reinforcement phases that maintain structural integrity during large deformations, enabling both superior tissue integration and material stability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The porous material effectively reduces or prevents fibrous capsule formation and capsular contracture, enhancing the integration of implantable devices and minimizing scarring, while maintaining mechanical integrity and durability.
Implementation Method 1
coating the elastomer base with porogens to form an elastomer coated porogen mixture; treating the elastomer coated porogen mixture to form a porogen scaffold comprising fused porogens
Implementation Method 2
The porous material has a porosity of 80-90% and exhibits an elastic elongation of at least 80%
Implementation Method 3
the material exhibits an elastic elongation of at least 80%
Implementation Method 4
The porous materials promote cellular ingrowth in and around an implantable medical device and reduce or prevent a foreign body response
Data Source
Figure 1A~1B
Figure 2A~2D
Figure 3A~3D
AI summary
The present specification discloses porous materials, methods of forming such porous materials, biocompatible implantable devices comprising such porous materials, and methods of making such biocompatible implantable devices.